Reflux in the mouse model of urinary tract infection

Comment

J R Johnson. Infect Immun. 1998 Dec.

. 1998 Dec;66(12):6063-4.

doi: 10.1128/IAI.66.12.6063-6064.1998.

No abstract available

Comment on

Treatment of mice with staphylococcal enterotoxin B enhances resolution of an induced Escherichia coli urinary tract infection and stimulates production of proinflammatory cytokines.
Morin MD, Hopkins WJ. Morin MD, et al. Infect Immun. 1998 Jun;66(6):2466-70. doi: 10.1128/IAI.66.6.2466-2470.1998. Infect Immun. 1998. PMID: 9596704 Free PMC article.
Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains.
Hopkins WJ, Gendron-Fitzpatrick A, Balish E, Uehling DT. Hopkins WJ, et al. Infect Immun. 1998 Jun;66(6):2798-802. doi: 10.1128/IAI.66.6.2798-2802.1998. Infect Immun. 1998. PMID: 9596750 Free PMC article.

1. Hopkins W J, Gendron-Fitzpatrick A, Balish E, Uehling D T. Time course and host responses to Escherichia coliurinary tract infection in genetically distinct mouse strains. Infect Immun. 1998;66:2798–2802. - PMC - PubMed
1. Hopkins W J, Hall J A, Conway B P, Uehling D T. Induction of urinary tract infection by intraurethral inoculation with Escherichia coli: refining the murine model. J Infect Dis. 1995;171:462–465. - PubMed
1. Johnson J R, Manivel J C. Vesicoureteral reflux induces renal trauma in a mouse model of ascending, unobstructed pyelonephritis. J Urol. 1991;145:1306–1311. - PubMed
1. Johnson J R, Brown J J. Defining inoculation conditions for the mouse model of ascending urinary tract infection that avoid immediate vesicoureteral reflux yet produce renal and bladder infection. J Infect Dis. 1996;173:746–749. - PubMed
1. Mobley H L T, Jarvis K G, Elwood J P, Whittle D I, Lockatell C V, Rusell R G, Johnson D E, Donnenberg M S, Warren J W. Isogenic P-fimbrial deletion mutants of pyelonephritogenic Escherichia coli: the role of αGal(1-4)βGal binding in virulence of a wild-type strain. Mol Microbiol. 1993;10:143–155. - PubMed